You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

NITROLINGUAL PUMPSPRAY Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Nitrolingual Pumpspray, and what generic alternatives are available?

Nitrolingual Pumpspray is a drug marketed by Pohl Boskamp and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has seven patent family members in seven countries.

The generic ingredient in NITROLINGUAL PUMPSPRAY is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nitrolingual Pumpspray

A generic version of NITROLINGUAL PUMPSPRAY was approved as nitroglycerin by AM REGENT on May 24th, 1988.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NITROLINGUAL PUMPSPRAY?
  • What are the global sales for NITROLINGUAL PUMPSPRAY?
  • What is Average Wholesale Price for NITROLINGUAL PUMPSPRAY?
Drug patent expirations by year for NITROLINGUAL PUMPSPRAY
Drug Prices for NITROLINGUAL PUMPSPRAY

See drug prices for NITROLINGUAL PUMPSPRAY

Drug Sales Revenue Trends for NITROLINGUAL PUMPSPRAY

See drug sales revenues for NITROLINGUAL PUMPSPRAY

Pharmacology for NITROLINGUAL PUMPSPRAY
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation
Paragraph IV (Patent) Challenges for NITROLINGUAL PUMPSPRAY
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
NITROLINGUAL PUMPSPRAY Sublingual Spray nitroglycerin 400 mcg/spray, 4.9 g and 12 g bottles 018705 1 2012-04-17

US Patents and Regulatory Information for NITROLINGUAL PUMPSPRAY

NITROLINGUAL PUMPSPRAY is protected by one US patents.

Patents protecting NITROLINGUAL PUMPSPRAY

Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: METHOD OF TREATING ANGINA PECTORIS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pohl Boskamp NITROLINGUAL PUMPSPRAY nitroglycerin SPRAY, METERED;SUBLINGUAL 018705-002 Jan 10, 1997 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for NITROLINGUAL PUMPSPRAY

See the table below for patents covering NITROLINGUAL PUMPSPRAY around the world.

Country Patent Number Title Estimated Expiration
Hungary 208253 NITROGLYCERINE PUMPING SPRAY ⤷  Sign Up
Brazil PI0908577 preparação farmacêutica estável por longo tempo com a substância ativa trinitrato de glicerol ⤷  Sign Up
Germany 59106106 ⤷  Sign Up
Australia 2009224968 Long-term stable pharmaceutical preparation having the active ingredient glycerol trinitrate ⤷  Sign Up
Hungary T58515 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.